Status:
COMPLETED
COVID-19 Sero-prevalence Health Care Workers Kinshasa
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Collaborating Sponsors:
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Conditions:
SARS-CoV Infection
Seroprevalence
Eligibility:
All Genders
Brief Summary
This is a cohort study, in which the investigators will follow-up 650 health care workers (HCW) and a selection of their households (of COVID positive and COVID negative HCW) at baseline and in three ...
Detailed Description
Rationale: There is no information on how intense transmission of COVID-19 happens in Kinshasa, partly due to a reduced laboratory capacity for polymerase chain reaction (PCR) confirmation of acute c...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- For Both groups:
- Willing to provide written informed consent
- Being sick or having had COVID-19 is not an exclusion criterion
- Health care workers
- Health care worker (all categories from specialist doctors to allied and auxiliary health workers) of the selected health services
- foreseen to be employed (or place of internship) for the next three months in he selected health facility
- Household members
- Willing not to change the residence during the study period
- Household member of included Health care workers
- Exclusion criteria: not giving consent
Exclusion
Key Trial Info
Start Date :
July 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04699058
Start Date
July 17 2020
End Date
December 31 2021
Last Update
December 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Nationale de recherche Biomédicale
Kinshasa, Democratic Republic of the Congo